The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahmad, F.
Right arrow Articles by Manganiello, V. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmad, F.
Right arrow Articles by Manganiello, V. C.
The Journal of Immunology, 1999, 162: 4864-4875.
Copyright © 1999 by The American Association of Immunologists

IL-3 and IL-4 Activate Cyclic Nucleotide Phosphodiesterases 3 (PDE3) and 4 (PDE4) by Different Mechanisms in FDCP2 Myeloid Cells

Faiyaz Ahmad*, Guang Gao*, Ling Mei Wang{dagger}, Tova Rahn Landstrom{ddagger}, Eva Degerman{ddagger}, Jacalyn H. Pierce{dagger} and Vincent C. Manganiello1,*

* Pulmonary/Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, and {dagger} Laboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and {ddagger} Section for Molecular Signaling, Department of Cell and Molecular Biology, Lund University, Lund, Sweden

In FDCP2 myeloid cells, IL-4 activated cyclic nucleotide phosphodiesterases PDE3 and PDE4, whereas IL-3, granulocyte-macrophage CSF (GM-CSF), and phorbol ester (PMA) selectively activated PDE4. IL-4 (not IL-3 or GM-CSF) induced tyrosine phosphorylation of insulin-receptor substrate-2 (IRS-2) and its association with phosphatidylinositol 3-kinase (PI3-K). TNF-{alpha}, AG-490 (Janus kinase inhibitor), and wortmannin (PI3-K inhibitor) inhibited activation of PDE3 and PDE4 by IL-4. TNF-{alpha} also blocked IL-4-induced tyrosine phosphorylation of IRS-2, but not of STAT6. AG-490 and wortmannin, not TNF-{alpha}, inhibited activation of PDE4 by IL-3. These results suggested that IL-4-induced activation of PDE3 and PDE4 was downstream of IRS-2/PI3-K, not STAT6, and that inhibition of tyrosine phosphorylation of IRS molecules might be one mechnism whereby TNF-{alpha} could selectively regulate activities of cytokines that utilized IRS proteins as signal transducers. RO31-7549 (protein kinase C (PKC) inhibitor) inhibited activation of PDE4 by PMA. IL-4, IL-3, and GM-CSF activated mitogen-activated protein (MAP) kinase and protein kinase B via PI3-K signals; PMA activated only MAP kinase via PKC signals. The MAP kinase kinase (MEK-1) inhibitor PD98059 inhibited IL-4-, IL-3-, and PMA-induced activation of MAP kinase and PDE4, but not IL-4-induced activation of PDE3. In FDCP2 cells transfected with constitutively activated MEK, MAP kinase and PDE4, not PDE3, were activated. Thus, in FDCP2 cells, PDE4 can be activated by overlapping MAP kinase-dependent pathways involving PI3-K (IL-4, IL-3, GM-CSF) or PKC (PMA), but selective activation of PDE3 by IL-4 is MAP kinase independent (but perhaps IRS-2/PI3-K dependent).




This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
H. Wang and N. K. Edens
mRNA expression and antilipolytic role of phosphodiesterase 4 in rat adipocytes in vitro
J. Lipid Res., May 1, 2007; 48(5): 1099 - 1107.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. A. Lin and J. A. Boyce
IL-4 Regulates MEK Expression Required for Lysophosphatidic Acid-Mediated Chemokine Generation by Human Mast Cells
J. Immunol., October 15, 2005; 175(8): 5430 - 5438.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H.-F. Tang, Y.-H. Song, J.-C. Chen, J.-Q. Chen, and P. Wang
Upregulation of Phosphodiesterase-4 in the Lung of Allergic Rats
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 823 - 828.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Fujitsu, K. Fukuda, K. Kimura, K. Seki, N. Kumagai, and T. Nishida
Protection of Human Conjunctival Fibroblasts from NO-Induced Apoptosis by Interleukin-4 or Interleukin-13
Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 797 - 802.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Mei, L. S. Holst, T. R. Landstrom, C. Holm, D. Brindley, V. Manganiello, and E. Degerman
C2-Ceramide Influences the Expression and Insulin-Mediated Regulation of Cyclic Nucleotide Phosphodiesterase 3B and Lipolysis in 3T3-L1 Adipocytes
Diabetes, March 1, 2002; 51(3): 631 - 637.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Moon, R. Lee, R. Near, L. Weintraub, S. Wolda, and A. Lerner
Inhibition of PDE3B Augments PDE4 Inhibitor-induced Apoptosis in a Subset of Patients with Chronic Lymphocytic Leukemia
Clin. Cancer Res., February 1, 2002; 8(2): 589 - 595.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
G. Baillie, S. J. MacKenzie, and M. D. Houslay
Phorbol 12-myristate 13-acetate Triggers the Protein Kinase A-Mediated Phosphorylation and Activation of the PDE4D5 cAMP Phosphodiesterase in Human Aortic Smooth Muscle Cells through a Route Involving Extracellular Signal Regulated Kinase (ERK)
Mol. Pharmacol., November 1, 2001; 60(5): 1100 - 1111.
[Abstract] [Full Text]

Home page
 DiabetesHome page
L. O’Rourke, S. J. Yeaman, and P. R. Shepherd
Insulin and Leptin Acutely Regulate Cholesterol Ester Metabolism in Macrophages by Novel Signaling Pathways
Diabetes, May 1, 2001; 50(5): 955 - 961.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. M. McKay, F. Botelho, P. J. M. Ceponis, and C. D. Richards
Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability
Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G1094 - G1103.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. J. MacKenzie, G. S. Baillie, I. McPhee, G. B. Bolger, and M. D. Houslay
ERK2 Mitogen-activated Protein Kinase Binding, Phosphorylation, and Regulation of the PDE4D cAMP-specific Phosphodiesterases. THE INVOLVEMENT OF COOH-TERMINAL DOCKING SITES AND NH2-TERMINAL UCR REGIONS
J. Biol. Chem., May 26, 2000; 275(22): 16609 - 16617.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Ahmad, L.-N. Cong, L. Stenson Holst, L.-M. Wang, T. Rahn Landstrom, J. H. Pierce, M. J. Quon, E. Degerman, and V. C. Manganiello
Cyclic Nucleotide Phosphodiesterase 3B Is a Downstream Target of Protein Kinase B and May Be Involved in Regulation of Effects of Protein Kinase B on Thymidine Incorporation in FDCP2 Cells
J. Immunol., May 1, 2000; 164(9): 4678 - 4688.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. J. M. Ceponis, F. Botelho, C. D. Richards, and D. M. McKay
Interleukins 4 and 13 Increase Intestinal Epithelial Permeability by a Phosphatidylinositol 3-Kinase Pathway. LACK OF EVIDENCE FOR STAT 6 INVOLVEMENT
J. Biol. Chem., September 8, 2000; 275(37): 29132 - 29137.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. M. Croniger, C. Millward, J. Yang, Y. Kawai, I. J. Arinze, S. Liu, M. Harada-Shiba, K. Chakravarty, J. E. Friedman, V. Poli, et al.
Mice with a Deletion in the Gene for CCAAT/Enhancer-binding Protein beta Have an Attenuated Response to cAMP and Impaired Carbohydrate Metabolism
J. Biol. Chem., January 5, 2001; 276(1): 629 - 638.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Moore, T. L. Church, D. D. Chism, R. A. Panettieri Jr., and S. A. Shore
IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK
Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L847 - L853.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.